Tags

Type your tag names separated by a space and hit enter

Current development of COVID-19 diagnostics, vaccines and therapeutics.
Microbes Infect. 2020 Jul - Aug; 22(6-7):231-235.MI

Abstract

A novel coronavirus, designated as SARS-CoV-2, first emerged in Wuhan City, Hubei Province, China, in late December 2019. The rapidly increasing number of cases has caused worldwide panic. In this review, we describe some currently applied diagnostic approaches, as well as therapeutics and vaccines, to prevent, treat and control further outbreaks of SARS-CoV-2 infection.

Authors+Show Affiliations

Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, China.Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, China.Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, China.Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, China.Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, China.Research Center of Chinese Jujube, Hebei Agriculture University, Baoding, China.Lindsley F. Kimball Research Institute, New York Blood Center, New York, USA. Electronic address: ldu@nybc.org.Lindsley F. Kimball Research Institute, New York Blood Center, New York, USA; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, China. Electronic address: shibojiang@fudan.edu.cn.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

32387332

Citation

Zhang, Naru, et al. "Current Development of COVID-19 Diagnostics, Vaccines and Therapeutics." Microbes and Infection, vol. 22, no. 6-7, 2020, pp. 231-235.
Zhang N, Li C, Hu Y, et al. Current development of COVID-19 diagnostics, vaccines and therapeutics. Microbes Infect. 2020;22(6-7):231-235.
Zhang, N., Li, C., Hu, Y., Li, K., Liang, J., Wang, L., Du, L., & Jiang, S. (2020). Current development of COVID-19 diagnostics, vaccines and therapeutics. Microbes and Infection, 22(6-7), 231-235. https://doi.org/10.1016/j.micinf.2020.05.001
Zhang N, et al. Current Development of COVID-19 Diagnostics, Vaccines and Therapeutics. Microbes Infect. 2020 Jul - Aug;22(6-7):231-235. PubMed PMID: 32387332.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Current development of COVID-19 diagnostics, vaccines and therapeutics. AU - Zhang,Naru, AU - Li,Chaoqun, AU - Hu,Yue, AU - Li,Kangchen, AU - Liang,Jintian, AU - Wang,Lili, AU - Du,Lanying, AU - Jiang,Shibo, Y1 - 2020/05/06/ PY - 2020/04/30/received PY - 2020/05/01/accepted PY - 2020/5/11/pubmed PY - 2020/8/15/medline PY - 2020/5/11/entrez KW - Diagnostic approaches KW - SARS-CoV-2 KW - Therapeutics KW - Vaccines SP - 231 EP - 235 JF - Microbes and infection JO - Microbes Infect VL - 22 IS - 6-7 N2 - A novel coronavirus, designated as SARS-CoV-2, first emerged in Wuhan City, Hubei Province, China, in late December 2019. The rapidly increasing number of cases has caused worldwide panic. In this review, we describe some currently applied diagnostic approaches, as well as therapeutics and vaccines, to prevent, treat and control further outbreaks of SARS-CoV-2 infection. SN - 1769-714X UR - https://www.unboundmedicine.com/medline/citation/32387332/Current_development_of_COVID_19_diagnostics_vaccines_and_therapeutics_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1286-4579(20)30079-4 DB - PRIME DP - Unbound Medicine ER -